Cellect BioTech To Cooperate With Entegris

March 11, 2015 | The Israeli company Cellect Biotechnology announced that it was negotiating a strategic cooperation agreement with Entegris, a US company specializing in advanced plastic devices. Cellect partnered with Entegris on the development of a medical kit and, following positive feasibility tests, the companies are looking towards a binding cooperation agreement. “The purpose of the agreement is to enable Cellect to invest its resources in a breakthrough already at the current stage, while focusing on its core business – development of technology, because production will be carried out by a high-quality supplier like Entegris,” said Cellect CEO Shai Yarkoni. Cellect was founded in 2011 by Dr. Shai Yarkoni and Dr. Nadir Askenasy.